Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02414961

Ligand	Ligand name	Chain	PDB	Tanimoto
HXS	4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol	A,B	3CV6	0.71
BPZ	4,4'-cyclohexane-1,1-diyldiphenol	A	2ZKC	0.72
Y13	(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE	A	2EW6	0.72
DRQ	(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL	A,B	2G5O	0.75
EST	ESTRADIOL	A,B	1GWR	0.77
EST	ESTRADIOL	A	1FDS	0.77
EST	ESTRADIOL	A,B,C	1G50	0.77
EST	ESTRADIOL	A,B,C,D,E,F	1ERE	0.77
EST	ESTRADIOL	A,B	1A52	0.77
EST	ESTRADIOL	A	1FDT	0.77
EST	ESTRADIOL	A	2OCF	0.77
EST	ESTRADIOL	A,B,C	1QKU	0.77
EST	ESTRADIOL	A,B,C,D,L	1E6W	0.77
EST	ESTRADIOL	A	1IOL	0.77
EST	ESTRADIOL	H	1JNN	0.77
EST	ESTRADIOL	B	1QKT	0.77
EST	ESTRADIOL	A	1FDW	0.77
EST	ESTRADIOL	A,B	1AQU	0.77
EST	ESTRADIOL	A	1LHU	0.77
EST	ESTRADIOL	A	1A27	0.77
EST	ESTRADIOL	L	1JGL	0.77
EST	ESTRADIOL	A,B,E,F	1PCG	0.77
EST	ESTRADIOL	A,B,C,D	1FDU	0.77
EST	ESTRADIOL	A	2J7X	0.77
EST	ESTRADIOL	A,B	2D06	0.77
MA0	(1R)-6-HYDROXY-N-METHYL-N-[(1Z)-PROP-2-EN-1-YLIDENE]INDAN-1-AMINIUM	A,B	2C64	0.75
EED	(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL	A,B	2QGT	0.74
REN	(S)-reticuline	A	3FWA	0.7
REN	(S)-reticuline	A	3D2D	0.7
099	(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide	A,B	3HYG	0.75
C3D	(5R,6S)-6-PHENYL-5-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]-5,6,7,8-TETRAHYDRONAPHTHALEN-2-OL	A	2OUZ	0.76
EQU	EQUILENIN	A,B	1OGX	0.73
EQU	EQUILENIN	A,B,C,D,E,F	1QJG	0.73
EQU	EQUILENIN	A,B	1OH0	0.73
EQU	EQUILENIN	A	1W6Y	0.73
EQU	EQUILENIN	A,B	1CQS	0.73
EQU	EQUILENIN	A	1OGZ	0.73
EQU	EQUILENIN	A	1GS3	0.73
EQU	EQUILENIN	A	1OHO	0.73
HE7	4-{[(14beta,17alpha)-3-hydroxyestra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid	A,B,C,D	2Z77	0.7
ETC	(R,R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL	A,B	1L2I	0.73
ETC	(R,R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL	A,B	1L2J	0.73
2OH	4,4'-PROPANE-2,2-DIYLDIPHENOL	A	2E2R	0.71
2OH	4,4'-PROPANE-2,2-DIYLDIPHENOL	A	2P7G	0.71
EQI	EQUILIN	A,B	1EQU	0.72
AEH	4-(2-aminoethyl)-2-ethylphenol	A	3BUG	0.7
ALE	L-EPINEPHRINE	A	3PAH	0.7
ALE	L-EPINEPHRINE	A	2HKK	0.7
E3O	(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL	A	2J7Y	0.75
EZT	(17BETA)-17-{(E)-2-[2-(TRIFLUOROMETHYL)PHENYL]VINYL}ESTRA-1(10),2,4-TRIENE-3,17-DIOL	A,B	2P15	0.8
BM4	3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl-3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan-3-yl]phenol	X	2W6C	0.75
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQR	0.73
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQS	0.73
ESL	ESTRIOL	A	1X8V	0.75
ECS	2,3,17BETA-TRIHYDROXY-1,3,5(10)-ESTRATRIENE	A,B,C,D	2BW7	0.73
17M	17-METHYL-17-ALPHA-DIHYDROEQUILENIN	A,B	2B1Z	0.78
RHP	(3R)-3-(PROP-2-YNYLAMINO)INDAN-5-OL	A,B	1S3E	0.79
AOE	N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)-3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17-DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-7-YL]-N-METHYLUNDECANAMIDE	A	1HJ1	0.78
098	(3R)-N~2~-(cyclopropylmethyl)-N~1~-hydroxy-3-(3-hydroxybenzyl)-N~4~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-L-aspartamide	A,B	3HY9	0.71
3QC	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	A,B	2FME	0.75
AED	4-(2-aminoethyl)-2-cyclohexylphenol	A	3BUH	0.73
OI1	3-(4-HYDROXYBENZYL)-2-[1-({[2-(4-HYDROXYPHENYL)ETHYL]AMINO}CARBONYL)BUTYL]-4-OXO-3,6,11,11A-TETRAHYDRO-4H-PYRAZINO[1,2-B]ISOQUINOLIN-2-IUM-1-OLATE	A,B	1Q9D	0.7